BioNTech SE ( BNTX ) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies November 11, 2025 9:00 AM EST Company Participants Ugur Sahin - Co-Founder, CEO & Chair of the Management Board Özlem Türeci - Co-Founder, Chief Medical Officer & Member of Management Board Ilhan Celik Michael Wenger Ramón Zapata-Gomez - CFO & Member of Management Board Douglas Maffei - Vice President of Strategy & Investor Relations Annemarie Hanekamp - Chief Commercial Officer & Member of Management Board Conference Call Participants Daina Graybosch - Leerink Partners LLC, Research Division Tazeen Ahmad - BofA Securities, Research Division Jay Lee …

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.14 per share a year ago.

BP was responding to a release of refined products on the Olympic Pipeline System east of Everett, Washington, and had partially restored part of the system, the company said on Monday.

LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it priced $850 million aggregate principal amount of its 6.500% senior notes due 2031 (the “Notes”) to be sold in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons outside the United States in reliance on Regulation S under.

LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today announced its fourth major Vida portfolio acquisition of 2025, capping an unprecedented year of strategic exits and reinforcing the firm's disciplined, science-first approach to company building and investing. Earlier today, Halda Therapeutics announced its acquisition by Johnson & Johnson (NYSE: JNJ) for $3.05 billion, marking a historic moment for the Vida III portfolio. Hald.

Stephen Gengaro, Stifel, joins 'Fast Money' to talk his bullish take on Tesla.

Archer Aviation said on Monday it will supply its electric powertrain for the Omen autonomous air vehicle, being co-developed by U.S. defense technology firm Anduril Industries and UAE-based EDGE group.

Jim Bianco (@BiancoResearch) says inflation is a bigger problem for the economy instead of jobs. He explains how the "K-shaped economy" many experts have hinted toward is closely tied to rising inflation, using Target (TGT) as a barometer for his metrics.

DUBAI, United Arab Emirates--(BUSINESS WIRE)---- $ACHR--Archer Aviation Inc. (NYSE: ACHR) today announced an agreement to supply Anduril Industries and EDGE Group with Archer's dual use electric powertrain technology to accelerate the development and scaled production of Anduril's recently unveiled Omen Autonomous Air Vehicle system. The UAE has committed to an initial acquisition of 50 Omen systems, creating an established demand signal for the Omen system and Archer's powertrain technology. The agreeme.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Quanex Building Products Corporation (NYSE: NX) between December 12, 2024 and September 5, 2025, inclusive (the “Class Period”). Quanex is an international supplier of engineered home components and access solutions to the construction industry. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. T.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON BLUE OWL CAPITAL INC. (OWL), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 16, 2025, the Financial Times published an article d.

Flexible Solutions International, Inc. ( FSI ) Q3 2025 Earnings Call November 17, 2025 11:00 AM EST Company Participants Daniel O'Brien - President, CEO, Principal Financial & Accounting Officer and Director Conference Call Participants Timothy Clarkson - Van Clemens & Co. Incorporated David Marsh - Singular Research, LLC Gregg Hillman William Gregozeski - Greenridge Global LLC Manny Stoupakis - Geoinvesting, LLC Raymond Howe Presentation Operator Good day, everyone, and welcome to today's Flexible Solutions International's Third Quarter 2025 Financials Conference Call. [Operator Instructions] Please note, this call is being recorded, and I will be standing by if you should need …

JinkoSolar Holding Co., Ltd. ( JKS ) Q3 2025 Earnings Call November 17, 2025 7:30 AM EST Company Participants Stella Wang - Investor Relations Officer Xiande Li - Co-Founder, CEO & Chairman of the Board Gener Miao Mengmeng Li - Chief Financial Officer Haiyun Cao - CFO & Deputy GM Conference Call Participants Philip Shen - ROTH Capital Partners, LLC, Research Division Alan Lau - Jefferies LLC, Research Division Rajiv Chaudhri Tyler Bisset - Goldman Sachs Group, Inc., Research Division Presentation Operator Hello, ladies and gentlemen, and thank you for standing by for JinkoSolar Holding Co., Ltd.

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Freeport-McMoran Inc. (NYSE: FCX) securities between February 15, 2022 and September 24, 2025. Freeport is a mining company.

Forget about reshoring manufacturing without more skilled workers.

NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of CarMax, Inc. (NYSE: KMX) between June 20, 2025 and November 5, 2025, both dates inclusive (the "Class Period"). The Class Period was expanded to include more investors.

Market Domination Overtime anchor Josh Lipton breaks down the day's market action for November 17, 2025. Dow Jones Industrial Average sold off more than 500 points, while the S&P 500 and Nasdaq also slipped.

Covered call ETFs have soared in attention recently due to the combination of attractive yield and blue-chip tech stock exposure they provide. However, I think most of these funds are structurally flawed. There is one fund that mitigates most of these issues, making it potentially worthy of investment: the Goldman Sachs Nasdaq-100 Premium Income ETF.

ROCKVILLE, Md. , Nov. 17, 2025 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA) today announced that it has commenced an underwritten public offering of 3,000,000 shares of its common stock.

TGTX has seen rapid enrolment of the ENHANCE study which could allow a simplified dosing regime of IV Briumvi. A readout is possible for mid-2026. Investors may need to wait longer for the subcutaneous formulation of Briumvi to become available, with a readout from clinical work possible in late 2026 or early 2027. Kyverna Therapeutics's KYV-101 is emerging as a potential competitor to TGTX's Azer-cel in Multiple Sclerosis, although initial KYV-101 data is from a handful of patients.